285 related articles for article (PubMed ID: 7954026)
1. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
3. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Kośmicki M; Sadowski Z; Szwed H; Kowalik I
Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
[TBL] [Abstract][Full Text] [Related]
4. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
5. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
6. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
[TBL] [Abstract][Full Text] [Related]
7. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
Rao YV; Reddy KS; Wasir HS
Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
[TBL] [Abstract][Full Text] [Related]
9. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
10. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
[TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
Kośmicki M; Sadowski Z
Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
[TBL] [Abstract][Full Text] [Related]
13. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
Parker JO; Farrell B; Lahey KA; Moe G
N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
Becker HJ; Fach WA; Weil J; Hüwer HD
Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
[TBL] [Abstract][Full Text] [Related]
15. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
16. [Long-term effect of organic nitrates in angina pectoris: dependence on the form of administration and mode of stress].
Schneider W; Bussmann WD; Kober G; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 2():83-7; discussion 115-7. PubMed ID: 2531510
[TBL] [Abstract][Full Text] [Related]
17. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
Glasser SP; Gana TJ; Pascual LG; Albert KS
Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
[TBL] [Abstract][Full Text] [Related]
20. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
